[Immunisation schedule of the Spanish Association of Paediatrics: 2016 recommendations]
Insights
The Spanish Association of Paediatrics
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- The Spanish Association of Paediatrics' Advisory Committee on Vaccines (CAV-AEP) annually updates its recommended immunization schedule for children in Spain.
- Recent optimizations in the national schedule include pneumococcal and varicella vaccines for infants.
Purpose of the Study:
- To present the CAV-AEP's updated, evidence-based immunization schedule for children residing in Spain.
- To provide recommendations on both funded and unfunded vaccinations, including specific age groups and vaccination strategies.
Main Methods:
- Review of current scientific evidence on vaccine efficacy and safety.
- Analysis of the Spanish Ministry of Health's funded vaccination schedule.
- Formulation of recommendations by the CAV-AEP.
Main Results:
- The CAV-AEP recommends a 2+1 strategy for hexavalent (DTPa-IPV-Hib-HB) and 13-valent pneumococcal conjugate vaccines at 2, 4, and 12 months.
- Booster doses for Tdap and poliomyelitis at age 6, and Tdap for adolescents and pregnant women are advised.
- Two-dose schedules for MMR and varicella are recommended, with emphasis on improving human papillomavirus (HPV) vaccination coverage in girls and providing information to male adolescents.
- Unfunded vaccination recommendations include meningococcal B (BEXSERO) and rotavirus vaccines for all infants, with CAV-AEP advocating for meningococcal B inclusion in the national schedule.
- Annual influenza and hepatitis A vaccinations are recommended for at-risk populations.
Conclusions:
- The CAV-AEP's updated schedule provides optimal vaccination strategies for children in Spain.
- Key recommendations focus on completing primary vaccination series, administering booster doses, and expanding coverage for specific vaccines like HPV and meningococcal B.
- The committee urges the incorporation of meningococcal B vaccine into the national funded schedule.
Abstract:
The Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP) annually publishes the immunisation schedule which, in our opinion, estimates optimal for children resident in Spain, considering available evidence on current vaccines. We acknowledge the effort of the Ministry of Health during the last year in order to optimize the funded unified Spanish vaccination schedule, with the recent inclusion of pneumococcal and varicella vaccination in early infancy. Regarding the funded vaccines included in the official unified immunization schedule, taking into account available data, CAV-AEP recommends 2+1 strategy (2, 4 and 12 months) with hexavalent (DTPa-IPV-Hib-HB) vaccines and 13-valent pneumococcal conjugate vaccine. Administration of Tdap and poliomyelitis booster dose at the age of 6 is recommended, as well as Tdap vaccine for adolescents and pregnant women, between 27-36 weeks gestation. The two-dose scheme should be used for MMR (12 months and 2-4 years) and varicella (15 months and 2-4 years). Coverage of human papillomavirus vaccination in girls aged 11-12 with a two dose scheme (0, 6 months) should be improved. Information for male adolescents about potential beneficial effects of this immunisation should be provided as well. Regarding recommended unfunded immunisations, CAV-AEP recommends the administration of meningococcal B vaccine, due to the current availability in Spanish communitary pharmacies, with a 3+1 scheme (3, 5, 7 and 13-15 months). CAV-AEP requests the incorporation of this vaccine in the funded unified schedule. Vaccination against rotavirus is recommended in all infants. Annual influenza immunisation and vaccination against hepatitis A are indicated in population groups considered at risk.
More Related Videos
07:33Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors
Published on: May 1, 2019
09:17A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice
Published on: January 5, 2021
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Drug Dosing: Infants and Children
Vaccines
Respiratory Syncytial Virus Disease
